← Browse by Condition
Medical Condition

hydatidiform mole

Total Trials
2
Recruiting Now
2
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for hydatidiform mole sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
Hospices Civils de Lyon 1 trial
Women's Hospital School Of Medicine Zhejiang University 1 trial
NCT02892877
Recruiting

The French National Reference Centre of GTD

Enrollment
25,500 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT03785574
Recruiting

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Enrollment
30 pts
Location
China
Sponsor
Women's Hospital School Of Med...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology